These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32473102)

  • 1. Framework for the implementation of advanced HIV disease diagnostics in sub-Saharan Africa: programmatic perspectives.
    Ndlovu Z; Burton R; Stewart R; Bygrave H; Roberts T; Fajardo E; Mataka A; Szumilin E; Kerschberger B; Van Cutsem G; Ellman T
    Lancet HIV; 2020 Jul; 7(7):e514-e520. PubMed ID: 32473102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, predictors, and management of advanced HIV disease among individuals initiating ART in Senegal, West Africa.
    Benzekri NA; Sambou JF; Ndong S; Tamba IT; Faye D; Diallo MB; Diatta JP; Faye K; Sall I; Sall F; Manga NM; Malomar JJ; Ndour CT; Hawes SE; Seydi M; Gottlieb GS
    BMC Infect Dis; 2019 Mar; 19(1):261. PubMed ID: 30876400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.
    Rajasingham R; Smith RM; Park BJ; Jarvis JN; Govender NP; Chiller TM; Denning DW; Loyse A; Boulware DR
    Lancet Infect Dis; 2017 Aug; 17(8):873-881. PubMed ID: 28483415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/μl identifies districts in South Africa with advanced burden of disease.
    Coetzee LM; Cassim N; Sriruttan C; Mhlanga M; Govender NP; Glencross DK
    PLoS One; 2018; 13(6):e0198993. PubMed ID: 29894509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa.
    Larson BA; Rockers PC; Bonawitz R; Sriruttan C; Glencross DK; Cassim N; Coetzee LM; Greene GS; Chiller TM; Vallabhaneni S; Long L; van Rensburg C; Govender NP
    PLoS One; 2016; 11(7):e0158986. PubMed ID: 27390864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing advanced HIV disease and mortality in global HIV programming.
    Boyd AT; Oboho I; Paulin H; Ali H; Godfrey C; Date A; Sean Cavanaugh J
    AIDS Res Ther; 2020 Jul; 17(1):40. PubMed ID: 32650797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the implementation of new guidelines on the management of patients with HIV infection at an advanced HIV clinic in Kinshasa, Democratic Republic of Congo (DRC).
    Mangana F; Massaquoi LD; Moudachirou R; Harrison R; Kaluangila T; Mucinya G; Ntabugi N; Van Cutsem G; Burton R; Isaakidis P
    BMC Infect Dis; 2020 Oct; 20(1):734. PubMed ID: 33028245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: A mixed-methods evaluation.
    Gils T; Kamele M; Madonsela T; Bosman S; Ngubane T; Joseph P; Reither K; Bresser M; Vlieghe E; Decroo T; Ayakaka I; Lynen L; Van Heerden A
    PLoS One; 2023; 18(12):e0296197. PubMed ID: 38134020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for invasive fungal disease using non-culture-based assays among inpatients with advanced HIV disease at a large academic hospital in South Africa.
    van Schalkwyk E; Mhlanga M; Maphanga TG; Mpembe RS; Shillubane A; Iyaloo S; Tsotetsi E; Pieton K; Karstaedt AS; Sahid F; Menezes CN; Tsitsi M; Motau A; Wadula J; Seetharam S; van den Berg E; Sriruttan C; Govender NP
    Mycoses; 2020 May; 63(5):478-487. PubMed ID: 32125004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proportions of CD4 test results indicating advanced HIV disease remain consistently high at primary health care facilities across four high HIV burden countries.
    Lamp K; McGovern S; Fong Y; Atem CD; Nfetam JBE; Nzuobontane D; Bollinger T; Jani I; Sitoe N; Kiyaga C; Senyama G; Mangwendeza PM; Mtapuri-Zinyowera S; Doi N; Peter T; Sacks JA; Vojnov L
    PLoS One; 2020; 15(1):e0226987. PubMed ID: 31910221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
    Rajasingham R; Meya DB; Greene GS; Jordan A; Nakawuka M; Chiller TM; Boulware DR; Larson BA
    PLoS One; 2019; 14(1):e0210105. PubMed ID: 30629619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced HIV: diagnosis, treatment, and prevention.
    Prabhu S; Harwell JI; Kumarasamy N
    Lancet HIV; 2019 Aug; 6(8):e540-e551. PubMed ID: 31285181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced HIV disease: A review of diagnostic and prophylactic strategies.
    Lehman A; Ellis J; Nalintya E; Bahr NC; Loyse A; Rajasingham R
    HIV Med; 2023 Aug; 24(8):859-876. PubMed ID: 37041113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of point-of-care lateral flow urine lipoarabinomannan antigen testing in HIV-positive adults in South Africa.
    Mukora R; Tlali M; Monkwe S; Charalambous S; Karat AS; Fielding KL; Grant AD; Vassall A
    Int J Tuberc Lung Dis; 2018 Sep; 22(9):1082-1087. PubMed ID: 30092876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions to reduce mortality in sub-Saharan Africa among HIV-infected adults not yet on antiretroviral therapy.
    Peterson K; van Griensven J; Huis in 't Veld D; Colebunders R
    Expert Rev Anti Infect Ther; 2012 Jan; 10(1):43-50. PubMed ID: 22149613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
    Hosseinipour MC; Bisson GP; Miyahara S; Sun X; Moses A; Riviere C; Kirui FK; Badal-Faesen S; Lagat D; Nyirenda M; Naidoo K; Hakim J; Mugyenyi P; Henostroza G; Leger PD; Lama JR; Mohapi L; Alave J; Mave V; Veloso VG; Pillay S; Kumarasamy N; Bao J; Hogg E; Jones L; Zolopa A; Kumwenda J; Gupta A;
    Lancet; 2016 Mar; 387(10024):1198-209. PubMed ID: 27025337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-of-care CD4+ technology implementation in Free State, South Africa, was associated with improved patient health outcomes.
    Van Turha L; Maharaj K; Rose A; Boeke C; Peter TF; Vojnov L; Quevedo J; Tsibolane Y
    S Afr Med J; 2020 Jan; 110(2):126-131. PubMed ID: 32657683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal.
    Drain PK; Kleene JM; Coleman SM; Losina E; Katz JN; Giddy J; Ross D; Freedberg KA; Bassett IV
    HIV Med; 2015 Nov; 16(10):640-4. PubMed ID: 25958770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing deaths from cryptococcal meningitis: from bench to bedside.
    Roy M; Chiller T
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):715-7. PubMed ID: 21905781
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.